Tenders of Gwq Serviceplus Ag

Tenders of Gwq Serviceplus Ag

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Conclusion of non-exclusive discount agreements pursuant to Section 130 A Paragraph 8 SGB V with the active ingredient Metoprolol Plus Hct (95 mg/12.5 mg)
Closing Date10 Nov 2025
Tender AmountRefer Documents 

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Conclusion of non-exclusive discount agreements according to § 130a paragraph 8 Sgb V for the active substance Tostran(r) (testosterone 20 mg/g)
Closing Date11 Aug 2025
Tender AmountRefer Documents 

Gwq Serviceplus Ag Tender

Electrical and Electronics
Germany
Germany-düsseldorf: Pharmaceutical Products
Closing Date10 Feb 2025
Tender AmountRefer Documents 

Gwq Serviceplus Ag Tender

Healthcare and Medicine...+1Chemical Products
Germany
Conclusion of non-exclusive discount agreements pursuant to Section 130 A Paragraph 8 SGB V with the active ingredient epinephrine in the dosage form Ilo
Closing Date10 May 2026
Tender AmountRefer Documents 

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Auftragsbekanntmachung - Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Zidovudin/lamivudin/abacavir
Closing Date10 Nov 2025
Tender AmountRefer Documents 

Gwq Serviceplus Ag Tender

Germany
Germany – Pharmaceutical Products – Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Betamethason + Salicylsäure Loe
Closing Date10 May 2026
Tender AmountRefer Documents 

Gwq Serviceplus Ag Tender

Germany
Order Announcement - Conclusion of Non-Exclusive Discount Agreements According to Section 130 A Paragraph 8 SGB V for Medicines with the Active Ingredient Filgrastim and the Trade Name Neupogen(r)
Closing Date10 Oct 2025
Tender AmountRefer Documents 

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Brimonidin In Der Darreichungsform Edp
Closing Date10 May 2026
Tender AmountRefer Documents 

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Conclusion of non-exclusive discount agreements according to Section 130a Paragraph 8 SGB V for the active ingredient tofacitinib
Closing Date10 Sep 2025
Tender AmountRefer Documents 

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Auftragsbekanntmachung - Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Clobetasol (cre/loe/sal, Atc-code Adv: D07ad01)
Closing Date10 Nov 2025
Tender AmountRefer Documents 
131-140 of 190 active Tenders